ProPharma, Odyssey buy Croatia’s Clinres Farmacija

This move reinforces ProPharma's competitive position with a blend of high patient access and cost-effective clinical services, the company said in a press release.

Financial details were not disclosed.

Zagreb-headquartered Clinres Farmacija was set up in 2004. On the domestic market, it is a leading CRO offering a comprehensive suite of services to biotech, pharmaceutical, and medical device companies. Clinres Farmacija specialises in phase II - IV clinical trials, and offers a full range of regulatory services. With a strong regional presence across Central and Eastern Europe, Clinres Farmacija operates extensively in Croatia, Bosnia and Herzegovina, Serbia, Romania, Bulgaria, North Macedonia, Montenegro, Georgia, and Albania.

According to data from Croatia’s court registry, Clinres Farmacija is owned by CEO Romana Kajfez and Tanja Kajfez Novak.